Canary Speech Raises $13M in Funding to Expand AI-Based Healthcare Tools

Canary Speech Raises $13M in Series A Funding

Canary Speech raises $13M in Series A Funding

Canary Speech (Linkedin), a leader in vocal biomarker technology for mental health and neurological disorder screening, has secured $13M in Series A funding. With advancements in AI and increasing demand for advanced healthcare tools, Canary Speech is poised for significant growth in the healthcare industry.

Funding Amount: $13 million

Industry: Hospitals and Health Care

Employee Count: 11-50

CEO: Henry O'Connell (CEO Linkedin)

What Canary Speech needs to buy: Canary Speech is seeking partnerships with AI and machine learning experts, healthcare providers, and marketing and sales service providers. Companies specializing in AI, healthcare technology integration, and marketing services can collaborate with Canary Speech to further enhance their vocal biomarker technology, integrate it into existing healthcare systems, and effectively promote their solutions to the target market.

Canary Speech Raises $13M in Funding to Expand AI-Based Healthcare Tools

Canary Speech raises $13M in Series A Funding

Read more

Supio Raises $25M in Series A Funding for AI Platform and Operational Expansion

Katara Raises $2.2M in Funding for Expansion

"Planera Raises $13.5M in Funding to Expand Construction Scheduling Platform"

pgEdge Raises $10M for Expansion and Innovation in Distributed PostgreSQL Market